Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy
Conditions: Lymphoma; Malignant Mesothelioma; Malignant Pericardial Effusion; Malignant Pleural Effusion; Non-small Cell Lung Cancer; Small Cell Lung Cancer; Soft Tissue Sarcoma; Thymoma and Thymic CarcinomaInterventions: Drug: doxepin hydrochloride; Other: placebo; Procedure: quality-of-life assessment; Other: questionnaire administration; Other: laboratory procedureSponsors: Mayo Clinic; National Cancer Institute (NCI)Recruiting - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asbestosis | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Doxepin | Esophagus Cancer | Lymphoma | Mesothelioma | Pain | Radiation Therapy | Research | Sarcomas